Evidence map›Paper›PMID 42568349›Full record

ArticleProtein science : a publication of the Protein Society2026

Identification of a key water molecule involved in the macrophage migration inhibitory factor-catalyzed tautomerization of para-hydroxyphenylpyruvate using neutron crystallography.

Gabriela C Schröder, Gregg V Crichlow, Ewelina Jablonowski, Georgios Pantouris, Jay Nix, Naomi Chayen, Flora Meilleur, Elias J Lolis

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gabriela C SchröderDepartment of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, North Carolina, USA.
Gregg V CrichlowDepartment of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0003-0512-1031
Ewelina JablonowskiDepartment of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, USA.
Georgios PantourisDepartment of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0001-5547-1406
Jay NixMolecular Biology Consortium, Advanced Light Source, Lawrence Berkeley National Laboratory, Berkeley, California, USA.
Naomi ChayenDivision of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
Flora MeilleurDepartment of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, North Carolina, USA.
Elias J LolisDepartment of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-7902-7868

Funding

User Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PAUL David ADAMS, Gregory L Hura · 2017 to 2026
$28.6M
NIGMS NIH HHS P30 GM124169NIH HHS P30 GM124169-01
6 · The paper itself

Abstract

Neutron crystallography was used to determine a 2.5-Å resolution all-atom structure of macrophage migration inhibitory factor (MIF) interacting with 3-(4-hydroxyphenyl)-pyruvate (HPP). MIF is a pro-inflammatory, pro-tumorigenic protein that may be an attractive therapeutic target. MIF catalyzes the interconversion of the keto and enol forms of HPP by a tautomerase reaction. Although HPP is evidently not a physiological substrate of MIF, many compounds that inhibit this activity in enzymatic assays have been found also to inhibit physiological activities of MIF. Therefore, the MIF-catalyzed HPP tautomerization reaction is used in initial screening of compounds in the search for inhibitors of MIF physiological activity. The neutron diffraction-derived crystal structure reveals the position of a water molecule involved in the tautomerization reaction, and also confirms the charged state of lysine-32 in the active site. The structure confirms the previously proposed catalytic mechanism of MIF, with the N-terminal Pro-1 abstracting a proton to generate an HPP enolate intermediate which is subsequently protonated. The structure reported herein reveals that this proton is supplied by a neighboring water molecule. Along with the neutron structure, a room-temperature synchrotron x-ray crystal structure reveals a covalent adduct between HPP and MIF. While this adduct is a result of radiation-induced chemistry, its formation confirms the catalytic role of the active site residue because a covalent complex could only form if the reactive carbon of the substrate is correctly positioned by the enzyme.

Indexed as

Intramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsPhenylpyruvic AcidsWaterCatalytic DomainCrystallography, X-RayHumansModels, MolecularNeutron Diffraction4-hydroxyphenylpyruvic acidIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMIF protein, humanPhenylpyruvic AcidsWater3‐(4‐hydroxyphenyl)‐pyruvateHPPketo‐enol tautomerizationmacrophage migration inhibitory factorMIFneutron crystallography

Identifiers

PMID42568349
PMCPMC13451966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.